Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.371
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Fasted Clinical Chemistry / Glycerol
|
HOM
|
f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.000333
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / Glycerol
|
HOM
|
8f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.396
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Glycerol
|
HET
|
3f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.439
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HET
|
3f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00295
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HOM
|
8f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.00216
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HET
|
3f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.412
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HOM
|
9f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.711
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Fasted Clinical Chemistry / Free fatty acids
|
HOM
|
9f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.00309
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Free fatty acids
|
HET
|
3f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0382
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / Free fatty acids
|
HOM
|
8f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.155
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / Triglycerides
|
HOM
|
8f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.0405
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Triglycerides
|
HET
|
3f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0452
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / Total cholesterol
|
HOM
|
8f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.122
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Total cholesterol
|
HET
|
3f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.281
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Fasted Clinical Chemistry / Total cholesterol
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.933
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Fasted Clinical Chemistry / Glucose
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.0315
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Glucose
|
HET
|
3f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.176
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / Glucose
|
HOM
|
8f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.180
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.440
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0497
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
8f:16m
|
Linear Mixed Model framework, LME, not including Weight
|
0.156
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Glucose
|
HOM
|
6f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.443
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Urea
|
HOM
|
4f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0634
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
8f:16m
|
Linear Mixed Model framework, LME, not including Weight
|
0.174
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.423
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0406
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.160
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
8f:16m
|
Linear Mixed Model framework, LME, not including Weight
|
0.354
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Sodium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
2.76×10-06
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
8f:16m
|
Linear Mixed Model framework, LME, not including Weight
|
0.221
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.280
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Potassium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000122
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0699
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
8f:16m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.245
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0812
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
2.33×10-06
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.426
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat Production (Metabolic Rate)
|
HOM
|
f:343m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0405
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:343m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.974
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.499
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.501
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.715
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.315
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
6f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.522
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.702
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.419
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0177
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00768
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
1.23×10-05
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0996
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
5f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.251
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
DEXA / Fat mass
|
HOM
|
8f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.284
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
DEXA / Fat mass
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.611
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
DEXA / Fat mass
|
HET
|
3f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.709
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000296
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Dysmorphology / fat distribution
|
HOM
|
8f:6m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
Dysmorphology / fat distribution
|
HET
|
3f:4m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / fat distribution
|
HOM
|
14f:10m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.154
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.532
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.000475
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.372
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.495
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Thyroxine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0686
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.680
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:155m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
Simplified IPGTT / Glucose response AUC
|
HET
|
3f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.00968
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Simplified IPGTT / Glucose response AUC
|
HOM
|
8f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0215
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Simplified IPGTT / Glucose response AUC
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.934
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Cumulative food intake
|
HOM
|
f:325m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.644
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.112
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Simplified IPGTT / Blood glucose concentration
|
HOM
|
40f:20m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
Simplified IPGTT / Blood glucose concentration
|
HET
|
15f:20m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Simplified IPGTT / Blood glucose concentration
|
HOM
|
70f:45m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.261
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.496
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.926
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
IPGTT / Blood glucose concentration
|
HOM
|
25f:35m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
IPGTT / Blood glucose concentration
|
HOM
|
10f:5m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.634
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.155
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.226
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
DEXA / Fat/Body weight
|
HOM
|
8f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.338
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
DEXA / Fat/Body weight
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.683
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
DEXA / Fat/Body weight
|
HET
|
3f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.698
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:155m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Calorimetry / Carbon dioxide production
|
HOM
|
1066f:719m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Carbon dioxide production
|
HET
|
189f:252m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
2f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.132
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.153
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
8f:16m
|
Linear Mixed Model framework, LME, not including Weight
|
0.988
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0942
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Calorimetry / Oxygen consumption
|
HOM
|
1066f:719m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Oxygen consumption
|
HET
|
189f:252m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0369
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
8f:16m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
1.77×10-08
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Triglyceride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.926
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Heat production (metabolic rate)
|
HET
|
189f:252m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.146
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.239
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0596
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.174
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.243
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0615
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0543
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
5f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.000392
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.116
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0201
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.844
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.157
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:155m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Dexa-scan analysis / Fat Mass
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
3.84×10-05
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Chloride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00171
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
8f:16m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0924
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.941
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.421
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
3f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
8f:16m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000169
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0316
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total protein
|
HOM
|
4f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
1.50×10-08
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00209
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
2f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000425
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
8f:16m
|
Linear Mixed Model framework, LME, not including Weight
|
7.91×10-06
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
1.03×10-05
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Calcium
|
HOM
|
4f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
1.36×10-05
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
8f:16m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0207
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.127
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0914
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Total food intake
|
HET
|
3f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.726
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.742
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:35m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
4f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.996
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
8f:16m
|
Linear Mixed Model framework, LME, not including Weight
|
6.09×10-05
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Phosphorus
|
HOM
|
4f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0448
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.234
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Iron
|
HOM
|
6f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0429
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.433
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
8f:16m
|
Linear Mixed Model framework, LME, not including Weight
|
0.472
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0519
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
8f:16m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0749
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.204
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00301
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
8f:16m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
3.19×10-05
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0771
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.301
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
8f:16m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00684
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.919
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.940
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0471
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
8f:16m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.657
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
2f:m
|
|
|
NotProcessed |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0148
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
8f:16m
|
Linear Mixed Model framework, LME, not including Weight
|
6.11×10-05
|
Successful |
Slc38a10tm2a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
1.71×10-05
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.651
|
Successful |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Dysmorphology / Body fat distribution
|
HOM
|
8f:8m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc38a10tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.249
|
Successful |